Novel treatment strategy for leg and sternal wound complications after coronary artery bypass graft surgery: Bioengineered Apligraf

Annals of Thoracic Surgery

Volumn 78, Issue 2, 2004, Pages 673-678

  Allie, David E ^a,b   Hebert, Chris J ^a   Lirtzman, Mitchell D ^a   Wyatt, Charles H ^a   Keller, V Antoine ^a   Souther, Stella M ^a   Allie, Adam A ^a   Mitran, Elena V ^a   Walker, Craig M ^a  

^a Cardiovasc Inst S SW Med Ctr ^*  (United States)

^b Cardiothoracic and Endovascular Surgery   (United States)

Author keywords

18

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DEBRIDEMENT; FEMALE; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SAPHENOUS VEIN; STERNUM; SURGICAL WOUND; TISSUE GRAFT; TREATMENT OUTCOME; WOUND CARE; WOUND DRESSING; WOUND HEALING;

AGED; ANGINA, UNSTABLE; BIOLOGICAL DRESSINGS; CORONARY ARTERY BYPASS; CYTOKINES; DIABETES COMPLICATIONS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLASTS; GROWTH SUBSTANCES; HUMANS; LEG; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOTOMY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SAPHENOUS VEIN; SKIN, ARTIFICIAL; STERNUM; SURGICAL WOUND DEHISCENCE; TISSUE AND ORGAN HARVESTING; TISSUE ENGINEERING; WOUND HEALING;

EID: 3242761628     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2003.09.032     Document Type: Article

References (11)

1. L'Ecuyer P.B., Murphy D., Little J.R., Frayser V.J. The epidemiology of chest and leg wound infections following cardiothoracic surgery. Clin Infect Dis. 22:1996;424-429
2. El Oakley R.M., Wright J.E. Postoperative mediastinitis classification and management. Ann Thorac Surg. 61:1996;1030-1036
3. Atillasoy E. The safety and efficacy of Apligraf (Apligraf) in the treatment of venous leg ulcers a multicenter, randomized, clinical trial. Wounds. 12:(Suppl A):2000;20-26
4. Falanga V., Margolis D., Alvarez O., et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogenic cultured human skin equivalent. Arch Dermatol. 134:1998;293-300
5. Sabolinski M.L., Alvarez O., Auletta M., et al. Cultured skin as a "smart material" for healing wounds expereince in venous ulcers. Biomaterials. 17:1996;311-320
6. Moneta G. Graftskin (Apligraf) in the treatment of venous leg ulcer optimal application techniques. Wounds. 12:(Suppl A):2000;27-32
7. Falanga V. Apligraf treatment of venous ulcers and other chronic wounds. J Dermatol. 25:1998;812-817
8. Milstone L., Asgari M., Schwartz P., Hardin-Young J. Growth factor expression, healing, and structural characteristics of Graftskin (Apligraf). Wounds. 12:(Suppl A):2000;12-19
9. Harder J., Bartels J., Christophers E., Schröder J.M. A peptide antibiotic from the human skin. Nature. 387:1997;861
10. Curran M.P., Plosker G.L. Bilayered bioengineered skin substitute (Apligraf). A review of its use in the treatment of venous leg ulcers and diabetic foot ulcers. Biodrugs. 16:2002;439-455
11. Kirsner R.S., Fastenau J., Falabella A., Valencia I., Long R., Eaglestein W.H. Clinical and economic outcomes with Graftskin for hard-to-heal venous leg ulcers. A single-center experience. Dermatol Surg. 28:2002;81-82